Agape ATP Corporation (NASDAQ:ATPC) Sees Significant Decline in Short Interest

Agape ATP Corporation (NASDAQ:ATPC) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 6,875 shares, a decrease of 78.6% from the March 31st total of 32,192 shares. Approximately 0.7% of the shares of the company are sold short. Based on an average trading volume of 98,447 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

ATPC has been the topic of several research analyst reports. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a report on Sunday, April 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC lifted its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. Institutional investors and hedge funds own 0.01% of the company’s stock.

Agape ATP Stock Performance

Shares of ATPC opened at $2.29 on Monday. Agape ATP has a 12 month low of $1.72 and a 12 month high of $123.00. The firm’s 50 day moving average is $2.61 and its 200-day moving average is $21.95. The stock has a market capitalization of $2.29 million, a PE ratio of -0.16 and a beta of -0.99.

Agape ATP (NASDAQ:ATPC) last announced its earnings results on Monday, April 13th. The company reported ($0.35) EPS for the quarter. Agape ATP had a negative return on equity of 9.91% and a negative net margin of 149.90%.The business had revenue of $0.40 million for the quarter.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.